Literature DB >> 10395883

Effect of immune activation induced by Cryptosporidium parvum whole antigen on in vitro human immunodeficiency virus type 1 infection.

L Xiao1, R B Lal, A A Lal.   

Abstract

Previous epidemiologic investigations have suggested that persons with AIDS who are infected with Cryptosporidium parvum have a shorter survival time than those with other opportunistic infections. In this study, the effect of immune activation by a crude Cryptosporidium whole antigen on human immunodeficiency virus type 1 (HIV-1) infection was evaluated. Peripheral blood mononuclear cells from healthy persons without HIV-1 infection had increased proliferative and cytokine (interleukin-4, interferon-gamma, and tumor necrosis factor [TNF]-alpha) responses to stimulation with the crude Cryptosporidium whole antigen. This stimulation increased HIV-1 p24 antigen production in in vitro infection by>30-fold. A similar increase in p24 production was also seen when stimulation was done after cells were infected with HIV-1. Neutralization of TNF-alpha reduced Cryptosporidium antigen-induced p24 production by >50%. Results of this study suggest that Cryptosporidium-induced immune activation may be a cofactor in regulating HIV-1 production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395883     DOI: 10.1086/314885

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1.

Authors:  Patricia C Guenthner; W Evan Secor; Charlene S Dezzutti
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  HIV and intestinal parasite co-infections among a Chinese population: an immunological profile.

Authors:  Li-Guang Tian; Tian-Ping Wang; Shan Lv; Feng-Feng Wang; Jian Guo; Xiao-Mei Yin; Yu-Chun Cai; Mary Kathryn Dickey; Peter Steinmann; Jia-Xu Chen
Journal:  Infect Dis Poverty       Date:  2013-08-23       Impact factor: 4.520

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.